LITTLE FALLS, N.J.,
May 31, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMN) will
release the results for its third quarter ended April 30, 2013 on Thursday, June 6 before the market opens, and
hold a conference call to discuss the results at 11:00 AM EDT. Participating in the call will be
Charles M. Diker, Chairman;
Andrew A. Krakauer, President and
CEO; Jorgen B. Hansen, Executive
Vice President and COO; Craig A.
Sheldon, Senior Vice President, CFO and Treasurer; and
Seth Yellin, Senior Vice
President-Corporate Development.
To participate in the conference call, dial (877) 407-8033
approximately 5 to 10 minutes before the beginning of the call. If
you are unable to participate, a digital replay of the call will be
available from Thursday, June 6, 2013
at 2:00 PM through midnight on
August 6, 2013 by dialing (877)
660-6853 and using conference ID # 415610.
The call will be simultaneously broadcast live over the Internet
on vcall.com at
http://www.investorcalendar.com/IC/CEPage.asp?ID=171058. A replay
of the webcast will be available on Vcall for 90 days.
About Cantel Medical Corp.
Cantel Medical Corp.
(NYSE:CMN) is a leading provider of infection prevention and
control products in the healthcare market. Our products include
water purification equipment, sterilants, disinfectants and
cleaners, specialized medical device reprocessing systems for
endoscopy and renal dialysis, disposable infection control products
primarily for dental and GI endoscopy markets, dialysate
concentrates and other dialysis supplies, hollow fiber membrane
filtration and separation products for medical and non-medical
applications, and specialty packaging for infectious and biological
specimens. We also provide technical maintenance for our products
and offer compliance training services for the transport of
infectious and biological specimens. For further information,
visit the Cantel website at http://www.cantelmedical.com.
SOURCE Cantel Medical Corp.